Imagine a temporary internal sleeve that acts like a detour pipe for waste after colon surgery. Instead of cutting a hole in the belly for a waste bag, this sleeve keeps everything inside and protects the healing joint. It is simply pulled out 10 days later without needing another surgery.
Colorectal surgery often leads to anastomotic leaks in 22% of cases, forcing surgeons to use diverting stomas. These stomas reduce patient quality of life and require a second invasive surgery to reverse.
An elastic tubular sheath (CG-100) that creates an internal bypass for colon content and is removed non-surgically after 10 days.
If you are a manufacturer dealing with high-precision medical tubing — this project developed a specialized elastic tubular sheath that requires scale-up manufacturing. It aims to reduce the need for diverting stomas by at least 70%.
If you are a hospital dealing with high re-operation rates and long patient stays due to anastomotic leaks — this project developed the CG-100 device. It can reduce healthcare costs by €4B per year in the EU by avoiding stoma-related complications.
If you are a distributor dealing with a gap in post-operative leak prevention — this project developed a non-surgical removal bypass device. It targets a market with 2 million annual new colorectal cancer cases.
Based on available project data, the device is expected to reduce healthcare costs by €4B per year in the EU.
Colospan has started a product specification modification process for scale-up manufacturing with a leading European silicone design and manufacturing partner.
An IP review was conducted during the design process, and a 3rd family of patents is scheduled to be executed within 12 months of the project.
The clinical team has drafted and finalized a full package of trial documents for pivotal trial preparations.
The project period is from 2022-06-01 to 2025-05-31.
The project is led by a single SME, Colospan Ltd from Israel, indicating a lean, founder-driven commercialization strategy. While the consortium consists of only 1 partner, they have successfully integrated an external European silicone manufacturing partner to handle industrial scale-up, bridging the gap between a small SME and mass production.
Contact Colospan Ltd regarding the CG-100 product line extension and clinical trial partnerships.
Contact us to explore licensing opportunities for the CG-100 bypass technology.
